908 Devices (NASDAQ:MASS – Get Rating) is one of 28 publicly-traded companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it compare to its competitors? We will compare 908 Devices to related businesses based on the strength of its analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk.
Insider & Institutional Ownership
79.2% of 908 Devices shares are held by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by institutional investors. 51.1% of 908 Devices shares are held by insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
908 Devices has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. Comparatively, 908 Devices’ competitors have a beta of 1.03, meaning that their average share price is 3% more volatile than the S&P 500.
This table compares 908 Devices and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|908 Devices Competitors||-3,288.70%||4.83%||1.80%|
Valuation & Earnings
This table compares 908 Devices and its competitors revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|908 Devices||$42.21 million||-$22.17 million||-16.31|
|908 Devices Competitors||$2.66 billion||$435.24 million||11.09|
908 Devices’ competitors have higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This is a summary of current ratings for 908 Devices and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|908 Devices Competitors||154||686||951||28||2.47|
908 Devices presently has a consensus price target of $30.00, suggesting a potential upside of 109.06%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 27.28%. Given 908 Devices’ stronger consensus rating and higher possible upside, research analysts clearly believe 908 Devices is more favorable than its competitors.
908 Devices beats its competitors on 7 of the 13 factors compared.
About 908 Devices (Get Rating)
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.